The preDIlatation in tRanscathEter aortiC Valve implanTation Trial
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 170 participants.
Also called NCT02448927
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 170 participants
- Registry
-
NCT02448927
-
- Other papers using this trial's data
- Pre-Dilatation Versus No Pre-Dilatation for Implantation of a Self-Expanding Valve in All Comers Undergoing TAVR: The DIRECT Trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Greece, Israel
- Registry status
- Completed
Technical summary
Registry record NCT02448927. Randomized; triple masking; primary purpose treatment. Start 2015-05 (registry gives no type); primary completion 2018-05-02 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The preDIlatation in tRanscathEter aortiC Valve implanTation Trial
- Acronym
- DIRECT
- Condition
- Aortic Valve Stenosis
- Intervention (Device)
- balloon aortic valvuloplasty
- Intervention (Device)
- Transcatheter Aortic Valve Implantation
- Lead sponsor
- National and Kapodistrian University of Athens
Record details
- Record id
cardio:ct-nct02448927- Content hash
8851a0cdd63ceadc0803be33f0491089beab6eec143cd1a6fa5ac93e12be7730